Validity and reliability of Arabic version of pediatric migraine disability assessment scale (Child Self-Report versus Parent Proxy-Report): a multi-center study

Table 2 Migraine characteristics in the included patients

Migraine characteristics		Patients (n = 112)
MMD [median (IQR)]		5 (4)
VAS [median (IQR)]		7 (2)
Disease duration in years [median (IQR)]		2 (2)
Type of migraine	Episodic [n (%)]	103 (92.0%)
Type of migraine	Chronic [n (%)]	9 (8.0%)
Aura	Without Aura [n (%)]	81 (72.3%)
Aura	With aura [n (%)]	31 (27.7%)
Prophylactic treatment	On treatment^a [n (%)]	83 (74.1%)
Prophylactic treatment	No treatment [n (%)]	29 (25.9%)

MMD Monthly migraine days, VAS Visual analogue scale, IQR Interquartile range
^a37 patients on propranolol, 34 on cyproheptadine, and 12 on valproate

ISSN: 1129-2377